Overview

A Study to Assess the Feasibility of an E-Health System (ZEMY) Designed to Manage Symptoms in Participants With Breast Cancer Under Anti-Cancer Treatment

Status:
Completed
Trial end date:
2019-04-19
Target enrollment:
0
Participant gender:
Female
Summary
This is a three-month open-label, multicenter, interventional, single arm study located in France, designed to assess feasibility and reliability of the e-Health ZEMY software medical device under investigation for use by participants with breast cancer, who are starting an anti-cancer treatment at any stage of the disease, to manage disease symptoms and anti-cancer treatment-related toxicities while at home.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Hoffmann-La Roche
Criteria
Inclusion Criteria:

- Female patients with breast cancer starting a treatment including oral and/or
parenteral anti-cancer drugs (chemotherapy and/or targeted therapies, hormonotherapy)

- Inter-cycle duration between hospital visits ≥14 days (this period of time is
estimated to be consistent with a need for support during the home setting period)

- Patients shall be prescribed loperamide or any other anti-diarrheic treatment in case
of diarrhea and prescription for any medication indicated in case of nausea/vomiting

- Able to speak and read French and to use a smartphone embedding ZEMY, in the
investigator's judgment

- Able to comply with the study protocol, in the investigator's judgment

- Patient affiliated to the national social security or beneficiary to such insurance.

Exclusion Criteria:

- Pregnant

- Already enrolled in a clinical study involving experimental medication or eHealth
device

- Concomitant malignancy

- ECOG score >2

- Treated with single hormonotherapy, single surgery or single radiotherapy,
immunotherapy.

- Patient whose mental state renders her unable to understand the nature, purposes, and
consequences of the study

- Patient not trained to the use of ZEMY

- Patient not trained to take her blood pressure measurement

- Patient deprived of her liberty by judicial or administrative order.